Publications

Detailed Information

EGR3 as a Potential Susceptibility Gene for Schizophrenia in Korea

DC Field Value Language
dc.contributor.authorKim, Se Hyun-
dc.contributor.authorSong, Joo Yun-
dc.contributor.authorJoo, Eun-Jeong-
dc.contributor.authorLee, Kyu Young-
dc.contributor.authorKim, Yong Sik-
dc.contributor.authorAhn, Yong Min-
dc.date.accessioned2012-07-04T06:08:10Z-
dc.date.available2012-07-04T06:08:10Z-
dc.date.issued2010-10-
dc.identifier.citationAMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS; Vol.153B 7; 1355-1360ko_KR
dc.identifier.issn1552-4841-
dc.identifier.urihttps://hdl.handle.net/10371/78426-
dc.description.abstractEarly growth response (EGR) genes play critical roles in signal transduction in the brain, which is involved in neuronal activation, brain development, and synaptic plasticity. EGR genes, including EGR2, EGR3, and EGR4, showed significant association with schizophrenia in Japanese schizophrenic pedigrees. In particular, EGR3, which resides at the chromosomal location 8p21.3, was suggested to be a potential susceptibility gene in schizophrenia based on a study of Japanese cases. However, this requires further replication with an independent sample set. We investigated the association of the EGR3 and EGR2 genes, which were suggested as potential susceptibility genes for schizophrenia supported by both genetic association and postmortem brain expression studies, with schizophrenia in Korean patients. Along with 350 healthy individuals, 244 schizophrenic patients were analyzed. Among the four examined single-nucleotide polymorphisms (SNPs) of EGR3 (rs1008949, rs7009708, rs35201266, and rs3750192), SNP rs35201266 in intron 1 of the EGR3 gene showed a significant association with schizophrenia (P = 0.0008, chi(2) = 11.156, OR = 1.493), which withstands multiple testing correction. In addition, the "T-G-C-G`` haplotype of EGR3 was under-represented in the patients with schizophrenia (P = 0.0073, chi(2) = 7.188, OR = 0.697). However, an association between the SNPs of EGR2 (rs2295814 and rs2297488) and schizophrenia was not found. These findings are consistent with the previous genetic association of the EGR3 gene in Japanese cohorts, which is the first replication concerning the association of EGR3 with schizophrenia in an independent cohort. Taken together, EGR3 could be suggested as a compelling susceptibility gene in schizophrenia. (c) 2010 Wiley-Liss, Inc.ko_KR
dc.description.sponsorshipThis studywas supported by a grant from the Korea Health 21R&D
Project, Ministry for Health,Welfare and Family Affairs, Republic
of Korea (A030001).
ko_KR
dc.language.isoenko_KR
dc.publisherWILEY-LISSko_KR
dc.subjectearly growth response geneko_KR
dc.subjectimmediate early geneko_KR
dc.subjectgenetic associationko_KR
dc.subjectschizophreniako_KR
dc.titleEGR3 as a Potential Susceptibility Gene for Schizophrenia in Koreako_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김세현-
dc.contributor.AlternativeAuthor송주윤-
dc.contributor.AlternativeAuthor주은정-
dc.contributor.AlternativeAuthor이규영-
dc.contributor.AlternativeAuthor안용민-
dc.contributor.AlternativeAuthor김용식-
dc.identifier.doi10.1002/ajmg.b.31115-
dc.citation.journaltitleAMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS-
dc.description.citedreferenceMansour HA, 2009, BIPOLAR DISORD, V11, P701-
dc.description.citedreferenceTabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2-
dc.description.citedreferenceTian C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003862-
dc.description.citedreferenceGallitano-Mendel A, 2008, NEUROPSYCHOPHARMACOL, V33, P1266, DOI 10.1038/sj.npp.1301505-
dc.description.citedreferencePerry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010-
dc.description.citedreferenceDudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108-
dc.description.citedreferenceLohoff FW, 2008, NEUROPSYCHOBIOLOGY, V57, P55, DOI 10.1159/000129668-
dc.description.citedreferencePOIRIER R, 2008, FRONT NEUROSCI, V2, P47-
dc.description.citedreferenceGallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050-
dc.description.citedreferenceYamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104-
dc.description.citedreferencePoirier R, 2007, FRONT BEHAV NEUROSCI, V1, DOI 10.3389/neuro.08/006.2007-
dc.description.citedreferenceVerma V, 2007, NEUROSCI RES, V57, P17, DOI 10.1016/j.neures.2006.09.002-
dc.description.citedreferenceVerma V, 2006, NEUROSCIENCE, V143, P573, DOI 10.1016/j.neuroscience.2006.08.010-
dc.description.citedreferenceRedon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329-
dc.description.citedreferenceRoberts DS, 2006, J BIOL CHEM, V281, P29431, DOI 10.1074/jbc.C600167200-
dc.description.citedreferenceStraub RE, 2006, BIOL PSYCHIAT, V60, P81, DOI 10.1016/j.biopsych.2006.002-
dc.description.citedreferenceRiley B, 2006, EUR J HUM GENET, V14, P669, DOI 10.1038/sj.ejhg.5201571-
dc.description.citedreferenceGogos JA, 2006, TRENDS PHARMACOL SCI, V27, P226, DOI 10.1016/j.tips.2006.02.005-
dc.description.citedreferenceMexal S, 2005, MOL BRAIN RES, V139, P317, DOI 10.1016/j.molbrainres.2005.06.006-
dc.description.citedreferenceKim JJ, 2005, HUM GENET, V117, P511, DOI 10.1007/s00439-005-1334-8-
dc.description.citedreferenceRoberts DS, 2005, P NATL ACAD SCI USA, V102, P11894, DOI 10.1073/pnas.0501434102-
dc.description.citedreferenceBarrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457-
dc.description.citedreferenceKnapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007-
dc.description.citedreferenceJacobson C, 2004, P NATL ACAD SCI USA, V101, P12218, DOI 10.1073/pnas.0404240101-
dc.description.citedreferenceKathiresan S, 2004, EUR HEART J, V25, P1378, DOI 10.1016/j.ehj.2004.06.035-
dc.description.citedreferenceJoo EJ, 2004, COMPR PSYCHIAT, V45, P225, DOI 10.1016/j.comppsych.2004.02.007-
dc.description.citedreferenceBerrettini W, 2003, AM J MED GENET C, V123C, P59, DOI 10.1002/ajmg.c.20014-
dc.description.citedreferenceMiyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100-
dc.description.citedreferenceGerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100-
dc.description.citedreferenceHildeman DA, 2003, J CLIN INVEST, V111, P575, DOI 10.1172//JCI200318007-
dc.description.citedreferenceLohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071-
dc.description.citedreferenceStefansson H, 2003, AM J HUM GENET, V72, P83-
dc.description.citedreferenceStefansson H, 2002, AM J HUM GENET, V71, P877-
dc.description.citedreferenceOphoff RA, 2002, AM J HUM GENET, V71, P565-
dc.description.citedreferenceCordell HJ, 2002, AM J HUM GENET, V70, P124-
dc.description.citedreferenceChiu YF, 2002, MOL PSYCHIATR, V7, P658, DOI 10.1038/sj.mp.4001045-
dc.description.citedreferenceO`Donovan KJ, 2000, J NEUROCHEM, V75, P1352-
dc.description.citedreferenceMeaney MJ, 2000, J NEUROSCI, V20, P3926-
dc.description.citedreferenceO`Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167-
dc.description.citedreferenceKendler KS, 1999, AM J MED GENET, V88, P29-
dc.description.citedreferenceHerdegen T, 1998, BRAIN RES REV, V28, P370-
dc.description.citedreferenceBlouin JL, 1998, NAT GENET, V20, P70-
dc.description.citedreferenceMittelstadt PR, 1998, MOL CELL BIOL, V18, P3744-
dc.description.citedreferencevon der Kammer H, 1998, J BIOL CHEM, V273, P14538-
dc.description.citedreferenceSenba E, 1997, NEUROSCI RES, V29, P183-
dc.description.citedreferenceBeckmann AM, 1997, NEUROCHEM INT, V31, P477-
dc.description.citedreferenceJung HY, 1996, BIOL PSYCHIAT, V40, P503-
dc.description.citedreferenceNURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849-
dc.description.citedreferenceYAMAGATA K, 1994, LEARN MEMORY, V1, P140-
dc.description.citedreferenceNURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P844-
dc.description.tc4-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share